04-06-2014, 09:11 AM
I was a little surprised as well. However, ALZ is a sizable Australian integrated property company with 3 main core divisions with focus on mainly residential, industrial properties and small exposure in commercial.
As with Australian companies, the takeover process is never straight forward as it requires the blessing of the board of directors of the target company in order for a successful takeover.
Stockland acquired a beachhead of 19.9% for a start in ALZ but its outstanding share swap offer wasn't even allow a due diligence exercise until it was improved to slightly above A$4.30 with some cash portion.
For Towkay Charoen, I think he is willing to sacrifice the small money in order to see the cards of other players on the table (including ALZ as well) before showing hand. After F&N and APB, we should be well aware of his capability and the continued uncertainties surround his home base Thailand, we should never under-estimate his intentions with all his core assets.
More comments to follow.
GG
As with Australian companies, the takeover process is never straight forward as it requires the blessing of the board of directors of the target company in order for a successful takeover.
Stockland acquired a beachhead of 19.9% for a start in ALZ but its outstanding share swap offer wasn't even allow a due diligence exercise until it was improved to slightly above A$4.30 with some cash portion.
For Towkay Charoen, I think he is willing to sacrifice the small money in order to see the cards of other players on the table (including ALZ as well) before showing hand. After F&N and APB, we should be well aware of his capability and the continued uncertainties surround his home base Thailand, we should never under-estimate his intentions with all his core assets.
More comments to follow.
GG
(04-06-2014, 08:51 AM)roxhockey Wrote: [ -> ]It's strange that Frasers didn't try to buy some stock after the CapitaLand sell down like Stockland did. Would have given them a stronger bidding position and cheaper economics.